Kyntra Bio Inc.
KYNB | NASDAQ
$4.57
-$0.08 (-1.72%)
At close: Oct 30, 2026, 4:00 PM ET
$4.69
+$0.12 (+2.63%)
After-hours:
Oct 30, 2026, 5:07 PM ET
-1.72%
(1D)No price chart data available for 1D timeframe.
Rating
49
+6.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #297/1028 (Top 29%)
Key Statistics
Market Data
Market Cap $18.5M
1D Range
4.46 4.70
52W Range
4.46 11.12
Valuation (TTM)
PE 0.08
PB -0.61
EV/EBITDA 0.77
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $28.00
Cash Flow
FCF Yield -205.7%
SBC Adj. FCF Yield -227.2%
SBC Impact -10.5%
Margins
Gross Margin 18.1%
Operating Margin -1101.0%
FCF Margin -824.4%
Growth (CAGR)
Revenue 3Y | 5Y -67.2% |
-51.5%
Dil EPS 3Y | 5Y 186.5% |
135.4%
FCF 3Y | 5Y 93.5% |
32.4%
Returns
ROA 181.2%
ROE -605.5%
ROIC -78.2%
Financial Health
Net Cash
$91.32M
Current Ratio 2.69
Interest Coverage -5.47
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market intr...
Sector Healthcare
Industry Biotechnology
Employees 34
IPO Date Nov 14, 2014
Website www.kyntrabio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$28.00
Upside
+512.69%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove KYNB